| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GBIO | Generation Bio Co. | Quinn Anthony G. | Director | Dec 01, 2023 | Buy | $1.41 | 88,495 | 124,778 | 88,495 | Dec 05, 2023, 04:30 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 16, 2022 | Buy | $2.34 | 80,079 | 187,705 | 550,540 | Mar 18, 2022, 06:46 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 11, 2022 | Buy | $2.06 | 34,777 | 71,780 | 363,572 | Mar 15, 2022, 06:32 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 14, 2022 | Buy | $1.93 | 67,472 | 130,221 | 431,044 | Mar 15, 2022, 06:32 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Mar 15, 2022 | Buy | $1.86 | 42,417 | 78,942 | 473,461 | Mar 15, 2022, 06:32 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Dec 09, 2021 | Buy | $3.70 | 43,108 | 159,500 | 318,269 | Dec 13, 2021, 08:39 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Dec 10, 2021 | Buy | $3.75 | 10,526 | 39,473 | 328,795 | Dec 13, 2021, 08:39 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Apr 30, 2020 | Buy | $4.75 | 165,000 | 783,750 | 538,469 | May 04, 2020, 07:30 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Oct 04, 2019 | Option Exercise | $6.28 | 18,265 | 114,689 | 371,908 | Oct 07, 2019, 04:09 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Jun 14, 2019 | Buy | $6.23 | 5,282 | 32,913 | 353,643 | Jun 14, 2019, 05:22 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Jun 12, 2019 | Buy | $6.11 | 12,217 | 74,705 | 333,955 | Jun 14, 2019, 05:22 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Jun 13, 2019 | Buy | $6.17 | 14,406 | 88,836 | 348,361 | Jun 14, 2019, 05:22 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 20, 2019 | Buy | $6.55 | 8,989 | 58,923 | 304,135 | May 22, 2019, 04:55 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 21, 2019 | Buy | $6.89 | 13,794 | 94,981 | 317,929 | May 22, 2019, 04:55 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 22, 2019 | Buy | $6.86 | 3,809 | 26,128 | 321,738 | May 22, 2019, 04:55 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Feb 15, 2019 | Buy | $7.10 | 719 | 5,103 | 277,152 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 15, 2019 | Buy | $6.76 | 6,256 | 42,269 | 283,408 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 16, 2019 | Buy | $6.83 | 5,520 | 37,691 | 288,928 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | May 17, 2019 | Buy | $6.65 | 6,218 | 41,335 | 295,146 | May 17, 2019, 05:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Feb 06, 2019 | Option Exercise | $6.18 | 8,756 | 54,126 | 276,433 | Feb 08, 2019, 04:15 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Dec 07, 2018 | Option Exercise | $4.37 | 171,890 | 751,816 | 267,677 | Dec 10, 2018, 05:40 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Feb 15, 2018 | Buy | $6.02 | 2,000 | 12,040 | 94,793 | Dec 10, 2018, 05:40 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | President & CEO | Aug 15, 2018 | Buy | $9.13 | 994 | 9,075 | 95,787 | Dec 10, 2018, 05:40 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Jul 12, 2018 | Option Exercise | $6.76 | 38,866 | 262,764 | 92,793 | Jul 16, 2018, 09:04 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Jul 11, 2018 | Option Exercise | $5.46 | 3,307 | 18,056 | 53,927 | Jul 13, 2018, 09:05 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Feb 15, 2018 | Option Exercise | $5.46 | 15,211 | 83,052 | 50,620 | Feb 20, 2018, 12:00 AM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Dec 06, 2017 | Buy | $4.92 | 4,888 | 24,072 | 32,009 | Dec 08, 2017, 07:06 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Dec 07, 2017 | Buy | $4.99 | 2,800 | 13,967 | 34,809 | Dec 08, 2017, 07:06 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Interim CEO | Dec 08, 2017 | Buy | $5.07 | 600 | 3,039 | 35,409 | Dec 08, 2017, 07:06 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Director | Dec 04, 2017 | Buy | $4.98 | 7,956 | 39,624 | 22,056 | Dec 05, 2017, 09:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Director | Dec 05, 2017 | Buy | $4.93 | 5,065 | 24,976 | 27,121 | Dec 05, 2017, 09:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony G. | Director | Dec 01, 2017 | Buy | $4.53 | 4,100 | 18,578 | 14,100 | Dec 05, 2017, 09:04 PM | |
| AGLE | Aeglea BioTherapeutics, Inc. | Quinn Anthony | Director | Apr 12, 2016 | Buy | $10.00 | 10,000 | 100,000 | 10,000 | Apr 12, 2016, 05:10 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO, & Head of R&D | Jun 22, 2015 | Option Exercise | $78.87 | 38 | 2,997 | 32,675 | Jun 23, 2015, 10:41 AM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Apr 27, 2015 | Sale | $55.85 | 20,000 | 1,117,000 | 15,637 | Apr 29, 2015, 05:28 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Apr 21, 2015 | Sale | $108.00 | 10,000 | 1,080,000 | 5,637 | Apr 23, 2015, 07:28 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Apr 15, 2015 | Option Exercise | $72.87 | 20,000 | 1,457,400 | 25,637 | Apr 17, 2015, 05:14 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Apr 06, 2015 | Option Exercise | $61.11 | 49,048 | 2,997,499 | 45,140 | Apr 08, 2015, 06:35 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Sep 02, 2014 | Sale | $46.57 | 20,000 | 931,404 | 35,595 | Sep 04, 2014, 05:21 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Jun 30, 2014 | Option Exercise | $54.89 | 71 | 3,897 | 25,595 | Jul 02, 2014, 05:56 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Apr 01, 2014 | Option Exercise | $0.95 | 10,000 | 9,500 | 25,524 | Apr 03, 2014, 09:56 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Apr 01, 2014 | Sale | $47.75 | 40,000 | 1,910,191 | 35,524 | Apr 03, 2014, 05:56 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | EVP, CMO & Head of R&D | Dec 31, 2013 | Option Exercise | $36.30 | 192 | 6,970 | 15,524 | Jan 02, 2014, 07:14 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jun 28, 2013 | Option Exercise | $35.68 | 297 | 10,597 | 15,332 | Jul 01, 2013, 05:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jan 18, 2013 | Sale | $25.52 | 18,894 | 482,080 | 24,482 | Jan 23, 2013, 05:05 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jan 16, 2013 | Sale | $47.03 | 5,706 | 268,360 | 20,388 | Jan 18, 2013, 05:00 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jan 17, 2013 | Sale | $25.47 | 400 | 10,190 | 15,235 | Jan 18, 2013, 05:00 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jul 26, 2012 | Option Exercise | $25.47 | 2,200 | 56,045 | 21,135 | Jul 30, 2012, 04:50 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jul 27, 2012 | Option Exercise | $25.59 | 12,800 | 327,581 | 26,435 | Jul 30, 2012, 04:50 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jul 19, 2012 | Option Exercise | $25.47 | 3,800 | 96,805 | 21,935 | Jul 23, 2012, 05:10 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jul 20, 2012 | Option Exercise | $25.47 | 1,200 | 30,570 | 20,635 | Jul 23, 2012, 05:10 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Quinn Anthony | SVP, Chief Medical Officer | Jun 25, 2012 | Sale | $40.65 | 26,000 | 1,056,874 | 20,035 | Jun 27, 2012, 05:25 PM |
Menu